Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06779617 · ClinicalTrials.gov registry record · NA
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
A NA study, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 150,000
- Enrollment target
NCT06779617: Recruiting NA study, sponsored by University of Maryland, Baltimore.
NCT06779617 is a NA study that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 150,000 participants, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (10607% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06779617, a NA study, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 150,000 participants
- Enrollment target
Study Summary
This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study is to improve provider awareness of a patient's risk of these two negative outcomes by providing them with new risk scores. The primary outcome will be the time from when the risk score becomes elevated to when vital signs such as heart rate or blood pressure are measured, suggesting an increased awareness.
Primary Outcome
Time to vital sign measurement after elevation of either the Sepsis Early Prediction System (SEPSys) or RESCUE Score. An elevated SEPSys or RESCUE Score is defined as a current SEPSys or RESCUE Score of 3 or 4 (highest risk) when the previous Score was a 1 (lowest risk) or 2.
Interventions
- DEVICE SEPSys
- DEVICE RESCUE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150,000 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06779617 shows while recruiting
NCT06779617 is an interventional study that assigns participants to a tested intervention. Its 150,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (10607% higher).
The record links to 0 conditions, and to 2 interventions - of which SEPSys is the first listed.
NCT06779617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06779617 about?
NCT06779617 is a clinical study titled "UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial". This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study is...
What is the current status of trial NCT06779617?
This trial is currently recruiting. It is a NA study. The enrollment target is 150,000 participants. The study started on 2026-02-01. Estimated completion is 2028-12.
What interventions are being tested in trial NCT06779617?
The interventions under investigation include: SEPSys (DEVICE), RESCUE (DEVICE).
Who is sponsoring clinical trial NCT06779617?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06779617's enrollment target sits among peer trials
150,000 2nd of 2000 the highest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI